Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress

Summary Inducible HSP70 (HSP70i) chaperones peptides from stressed cells, protecting them from apoptosis. Upon extracellular release, HSP70i serves an adjuvant function, enhancing immune responses to bound peptides. We questioned whether HSP70i differentially protects control and vitiligo melanocyte...

Full description

Saved in:
Bibliographic Details
Published in:Pigment cell and melanoma research Vol. 27; no. 2; pp. 209 - 220
Main Authors: Mosenson, Jeffrey A., Flood, Kelsey, Klarquist, Jared, Eby, Jonathan M., Koshoffer, Amy, Boissy, Raymond E., Overbeck, Andreas, Tung, Rebecca C., Le Poole, I. Caroline
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01-03-2014
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Inducible HSP70 (HSP70i) chaperones peptides from stressed cells, protecting them from apoptosis. Upon extracellular release, HSP70i serves an adjuvant function, enhancing immune responses to bound peptides. We questioned whether HSP70i differentially protects control and vitiligo melanocytes from stress and subsequent immune responses. We compared expression of HSP70i in skin samples, evaluated the viability of primary vitiligo and control melanocytes exposed to bleaching phenols, and measured secreted HSP70i. We determined whether HSP70i traffics to melanosomes to contact immunogenic proteins by cell fractionation, western blotting, electron microscopy, and confocal microscopy. Viability of vitiligo and control melanocytes was equally affected under stress. However, vitiligo melanocytes secreted increased amounts of HSP70i in response to MBEH, corroborating with aberrant HSP70i expression in patient skin. Intracellular HSP70i colocalized with melanosomes, and more so in response to MBEH in vitiligo melanocytes. Thus, whereas either agent is cytotoxic to melanocytes, MBEH preferentially induces immune responses to melanocytes.
Bibliography:istex:0E6ED6616EF2845D3A8E90A5A71731C055E7B5C1
Figure S1. HSP70i colocalizes with melanosomes in fractions from control as well as vitiligo melanocytes. Figure S2. Minimal background in confocal images where no primary antibody is used.
NIH
National Institute of Arthritis and Musculoskeletal and Skin Diseases - No. RO1AR054749
ark:/67375/WNG-F99T1281-M
ArticleID:PCMR12208
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1755-1471
1755-148X
DOI:10.1111/pcmr.12208